Market prospect of shell membrane polypeptide

It has a broad prospect in the field of diabetes. In the global hypoglycemic drug market, peptide drugs with shell membranes account for nearly 70%. In the cardiovascular field, although there are few kinds of peptide drugs listed in 2022, they will have broad development prospects under the development trend of high-efficiency and low-toxicity drugs in the future. In the field of tumor, polypeptide drugs with shell membrane have attracted wide attention because of their targeting, safety and specificity.